| Harnessing synthetic lethality to predict the response to cancer treatment JS Lee, A Das, L Jerby-Arnon, R Arafeh, N Auslander, M Davidson, ... Nature communications 9 (1), 2546, 2018 | 116 | 2018 |
| Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells DA Lichtenstein, F Schischlik, L Shao, SM Steinberg, B Yates, HW Wang, ... Blood, The Journal of the American Society of Hematology 138 (24), 2469-2484, 2021 | 100 | 2021 |
| AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 41 | 2022 |
| Deconvolving clinically relevant cellular immune cross-talk from bulk gene expression using CODEFACS and LIRICS stratifies patients with melanoma to anti–PD-1 therapy K Wang, S Patkar, JS Lee, EM Gertz, W Robinson, F Schischlik, ... Cancer discovery 12 (4), 1088-1105, 2022 | 31 | 2022 |
| Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy AD Sahu, J S Lee, Z Wang, G Zhang, R Iglesias‐Bartolome, T Tian, Z Wei, ... Molecular systems biology 15 (3), e8323, 2019 | 29 | 2019 |
| Neoantigen identification and response to adoptive cell transfer in anti–PD-1 naïve and experienced patients with metastatic melanoma ST Levi, AR Copeland, S Nah, JS Crystal, GD Ivey, A Lalani, M Jafferji, ... Clinical cancer research 28 (14), 3042-3052, 2022 | 24 | 2022 |
| Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer YA Kim, D Wojtowicz, R Sarto Basso, I Sason, W Robinson, ... Genome medicine 12, 1-12, 2020 | 22 | 2020 |
| Modeling clinical and molecular covariates of mutational process activity in cancer W Robinson, R Sharan, MDM Leiserson Bioinformatics 35 (14), i492-i500, 2019 | 19 | 2019 |
| Profiles of expressed mutations in single cells reveal subclonal expansion patterns and therapeutic impact of intratumor heterogeneity FR Mehrabadi, KL Marie, E Pérez-Guijarro, S Malikić, ES Azer, HH Yang, ... bioRxiv, 2021.03. 26.437185, 2021 | 9 | 2021 |
| Strain level microbial detection and quantification with applications to single cell metagenomics K Zhu, AA Schäffer, W Robinson, J Xu, E Ruppin, AF Ergun, Y Ye, ... Nature Communications 13 (1), 6430, 2022 | 8 | 2022 |
| CSI-Microbes: Identifying cell-type specific intracellular microbes from single-cell RNA-seq data W Robinson, F Schischlik, EM Gertz, JS Lee, K Zhu, SC Sahinalp, R Patro, ... bioRxiv, 2021 | 8* | 2021 |
| Putative functional genes in idiopathic dilated cardiomyopathy NU Nair, A Das, U Amit, W Robinson, SG Park, M Basu, A Lugo, J Leor, ... Scientific Reports 8 (1), 66, 2018 | 6 | 2018 |
| A sticky multinomial mixture model of strand-coordinated mutational processes in cancer I Sason, D Wojtowicz, W Robinson, MDM Leiserson, TM Przytycka, ... Iscience 23 (3), 2020 | 4 | 2020 |
| Deconvolving clinically relevant cellular immune crosstalk from bulk gene expression using CODEFACS and LIRICS K Wang, S Patkar, JS Lee, EM Gertz, W Robinson, F Schischlik, ... bioRxiv, 2021.01. 20.427515, 2021 | 3 | 2021 |
| Intraoperative ultrasound appearance of a pancreatic cerebral metastasis: a case report CA Donofrio, LR Barzaghi, JF Capitanio, A Cavalli, P Panni, S Snider, ... Journal of Neurological Surgery Part A: Central European Neurosurgery 79 (04 …, 2018 | 3 | 2018 |
| Biomarkers of response and acquired resistance to TIL-ACT in solid tumors W Robinson, A Castro, M Al-Bakir, JJ Gartner, CA Chamberlain, ... Cancer Research 84 (6_Supplement), 1-1, 2024 | | 2024 |
| Determining Optimal Placement of Copy Number Aberration Impacted Single Nucleotide Variants in a Tumor Progression History CH Wu, S Joshi, W Robinson, PF Robbins, R Schwartz, C Sahinalp, ... bioRxiv, 2024.03. 10.584318, 2024 | | 2024 |
| Medication effects on the gut microbiome in allo-HCT W Robinson, EM Gertz, TF Greten, E Ruppin Cell 186 (12), 2520-2523, 2023 | | 2023 |
| Deconvolving bulk gene expression to chart the immune activity and crosstalk in the tumor microenvironment K Wang, S Patkar, JS Lee, EM Gertz, W Robinson, F Schischlik, ... Cancer Research 81 (13_Supplement), 3179-3179, 2021 | | 2021 |
| Abstract A188: Harnessing synthetic lethality to predict the response to cancer treatments JS Lee, A Das, L Jerby-Arnon, R Arafeh, M Davidson, A Amzallag, ... Molecular Cancer Therapeutics 17 (1_Supplement), A188-A188, 2018 | | 2018 |
Eytan RuppinChief, Cancer Data Science Lab (CDSL), NCI/NIHAdresse e-mail validée de nih.gov
